Robert W. Hesslein, Senior VP & General Counsel at Voyager Therapeutics, Inc. (VYGR), sold 3,292 shares at $4.95 ($16K) on 2021-04-05, disclosed to the SEC on 2021-04-07.
Scheduled sale ($16k) by Senior VP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2023-02-15 | $22K | — | Filing → |
| VYGR | SELL | 2023-01-19 | $22K | — | Filing → |
| VYGR | SELL | 2022-04-06 | $23K | — | Filing → |